Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.59
Delayed Data
As of 12:37pm ET
 +0.17 / +2.02%
Today’s Change
6.90
Today|||52-Week Range
9.88
+0.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues59.7M63.1M60.8M60.5M
 
 
 
 
 
Cost of Goods Sold28.9M30.8M29.2M27.0M
 
 
 
 
 
Depreciation And Amortization5.6M5.4M6.0M6.2M
 
 
 
 
 
 
Operating ExpensesGross Income25.1M27.0M25.5M27.3M
 
 
 
 
 
General Expenses23.2M24.8M24.1M26.7M
 
 
 
 
 
Research And Development1.3M1.3M967.0K930.0K
 
 
 
 
 
Total Operating Expenses57.8M60.9M59.4M60.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.9M2.2M1.4M529.0K
 
 
 
 
 
Extraordinary Charge0.000.000.00-3.5M
 
 
Interest Expense On Debt1.6M1.4M1.5M5.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income329.0K745.0K-73.0K-8.4M
 
 
 
 
 
Income Taxes-174.0K-332.0K-6.0K-2.2M
 
 
 
 
 
Preferred Dividend-5.6M-5.6M-5.6M-8.0M
 
 
 
 
 
Net Income155.0K413.0K-67.0K-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS76.1M77.4M78.1M78.5M
 
 
 
 
 
Shares To Calculate EPS Diluted76.1M77.4M78.1M78.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.07-$0.07-$0.18
 
 
 
 
 
EPS Diluted-$0.07-$0.07-$0.07-$0.18